Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 22129192)

1.

Adenocarcinoma of the urinary bladder.

Roy S, Parwani AV.

Arch Pathol Lab Med. 2011 Dec;135(12):1601-5. doi: 10.5858/arpa.2009-0713-RS. Review.

PMID:
22129192
2.

Adenocarcinoma arising within ectopic prostatic tissue in the urinary bladder.

Backhouse A, Vasilaras A, Yung T, Kench JG.

Pathology. 2014 Dec;46(7):655-7. doi: 10.1097/PAT.0000000000000171. No abstract available.

PMID:
25393262
3.

[Diagnosis and differential diagnosis of malignant glandular and glandular-like lesions of the urinary bladder].

Cheng L, Huang WB, Rao Q.

Zhonghua Bing Li Xue Za Zhi. 2013 Jan;42(1):57-61. doi: 10.3760/cma.j.issn.0529-5807.2013.01.017. Chinese. No abstract available.

PMID:
23611280
4.

A rare metastasis to the bladder.

Modh RA, Corbyons KA, Yeung LL.

Case Rep Urol. 2013;2013:789039. doi: 10.1155/2013/789039. Epub 2013 Mar 3.

5.

[Primary thymic adenocarcinoma: report of a case].

Li SM, Wang ZQ, Wang HP, Zhou AD.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):639-40. doi: 10.3760/cma.j.issn.0529-5807.2012.09.018. Chinese. No abstract available.

PMID:
23157839
6.

Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge.

Roy S, Smith MA, Cieply KM, Acquafondata MB, Parwani AV.

Diagn Pathol. 2012 Nov 2;7:151. doi: 10.1186/1746-1596-7-151.

7.

Urinary bladder metastasis originating from lung adenocarcinoma: a case definitively diagnosed by immunohistochemistry.

Shirakawa H, Kozakai N, Sawafuji M, Sugiura H, Hara S.

Urol J. 2012 Spring;9(2):530-2. No abstract available.

8.

Keratin expression in colorectal cancer: freak of nature or significant finding?

Stewart C.

Histopathology. 2012 Apr;60(5):846-7. doi: 10.1111/j.1365-2559.2011.04124.x. Epub 2012 Jan 19. No abstract available.

PMID:
22260534
9.

Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.

Paner GP, McKenney JK, Barkan GA, Yao JL, Frankel WL, Sebo TJ, Shen SS, Jimenez RE.

Am J Surg Pathol. 2011 Jun;35(6):787-98. doi: 10.1097/PAS.0b013e3182189c11.

PMID:
21572312
10.

Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers.

Kapur P, Lotan Y, King E, Kabbani W, Mitra AP, Mosbah A, Abol-Enein H, Ghoneim M, Youssef RF.

Am J Clin Pathol. 2011 Jun;135(6):822-30. doi: 10.1309/AJCP76KUVOTBKQRY.

11.

Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis.

Brimo F, Herawi M, Sharma R, Netto GJ, Epstein JI, Illei PB.

Hum Pathol. 2011 Nov;42(11):1613-9. doi: 10.1016/j.humpath.2011.01.007. Epub 2011 Apr 14.

PMID:
21496868
12.

Metastatic adenocarcinoma of the colon: early manifestation in gingival tissue.

Soares AB, Thomaz LA, Duarte MT, de Camargo de Moraes P, de Araújo VC.

Head Neck Pathol. 2011 Jun;5(2):140-3. doi: 10.1007/s12105-010-0222-2. Epub 2010 Nov 16.

14.

Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia.

Hodges KB, Lopez-Beltran A, Emerson RE, Montironi R, Cheng L.

Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):401-10. doi: 10.1097/PAI.0b013e3181e04816. Review.

PMID:
20505509
15.

[Differential diagnostic importance of immunochistochemistry applied at metastases of adenocarcinomas of the peritoneum].

Porjazova E, Zaprjanov Z, Batashki I, Milchev N, Markova D.

Akush Ginekol (Sofiia). 2009;48(5):20-2. Bulgarian.

PMID:
20198793
16.

[Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].

Porjazova E, Zaprjanov Z, Batashki I, Markova D, Milchev N.

Akush Ginekol (Sofiia). 2009;48(2):7-12. Bulgarian.

PMID:
20198769
17.

The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease.

Perrotto J, Abbott JJ, Ceilley RI, Ahmed I.

Am J Dermatopathol. 2010 Apr;32(2):137-43. doi: 10.1097/DAD.0b013e3181b71481.

PMID:
20051815
18.

CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.

Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.

Jpn J Clin Oncol. 2010 Mar;40(3):208-13. doi: 10.1093/jjco/hyp150. Epub 2009 Nov 18.

19.

CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.

Saad RS, Silverman JF, Khalifa MA, Rowsell C.

Appl Immunohistochem Mol Morphol. 2009 May;17(3):196-201. doi: 10.1097/PAI.0b013e31819268f2. Erratum in: Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):464.

PMID:
19098678
20.

Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.

Westfall DE, Folpe AL, Paner GP, Oliva E, Goldstein L, Alsabeh R, Gown AM, Amin MB.

Am J Surg Pathol. 2009 Jan;33(1):99-105. doi: 10.1097/PAS.0b013e318180c899.

PMID:
18941404
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk